Currenc Group, Inc. ( CURR) - Stock Earnings
CURR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -4.7 million USD | 10.1 million USD |
| 2025Q2 | -4.7 million USD | 8.7 million USD |
| 2025Q3 | 2.9 million USD | 10.4 million USD |
CURR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -16.7 million USD | 55.5 million USD |
| 2023 | -15.3 million USD | 53.3 million USD |
| 2024 | -39.5 million USD | 46.4 million USD |
| 2026 Est. | — | — |
CURR
Price: $3.52
52 week price:
Earnings Per Share: -0.85 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 204.5 million